Friday 8 November 2013

Advaxis’s cancer vaccine gets FDA orphan status for treatment of HPV-associated head and neck cancer « New Drug Approvals

Advaxis’s cancer vaccine gets FDA orphan status for treatment of HPV-associated head and neck cancer « New Drug Approvals:

'via Blog this'

No comments:

Post a Comment